The aim of this case study was to measure the changes in BRD cases and antibiotics consumption using a combined NASYM (live attenuated BRSV vaccine-HIPRA) – HIPRABOVIS® SOMNI/Lkt (M. haemolytica leucotoxoid & H. somni vaccine-HIPRA) protocol in a commercial dairy farm with known respiratory problems and to calculate the return on investment (ROI) of the protocol used.
Reduction in BRD cases and antibiotics consumption using a combined NASYM and HIPRABOVIS® SOMNI/Lkt protocol in a commercial Polish dairy farm
An innovative service based on data analysis that facilitates decision-making in Cattle
Subscribe to our newletters and receive the latest news on Animal Health delivered straight to your inbox
Discover our latest news